| Product Code: ETC9409064 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Next Generation Bio therapeutics Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Next Generation Bio therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Next Generation Bio therapeutics Market - Industry Life Cycle |
3.4 South Korea Next Generation Bio therapeutics Market - Porter's Five Forces |
3.5 South Korea Next Generation Bio therapeutics Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.6 South Korea Next Generation Bio therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 South Korea Next Generation Bio therapeutics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 South Korea Next Generation Bio therapeutics Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 South Korea Next Generation Bio therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for next-generation biotherapeutics in South Korea |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Government support and favorable regulatory environment for biopharmaceuticals in South Korea |
4.3 Market Restraints |
4.3.1 High costs associated with the development and manufacturing of next-generation biotherapeutics |
4.3.2 Limited availability of skilled workforce and expertise in biopharmaceutical development |
4.3.3 Stringent regulatory requirements and approval processes for new biotherapeutic products |
5 South Korea Next Generation Bio therapeutics Market Trends |
6 South Korea Next Generation Bio therapeutics Market, By Types |
6.1 South Korea Next Generation Bio therapeutics Market, By Therapeutic Application |
6.1.1 Overview and Analysis |
6.1.2 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Therapeutic Application, 2021- 2031F |
6.1.3 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Oncology Next-Generation Antibody Therapeutics, 2021- 2031F |
6.1.4 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Autoimmune/Inflammatory Next-Generation Antibody Therapeutics, 2021- 2031F |
6.2 South Korea Next Generation Bio therapeutics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Antibody-Drug Conjugates (ADCs), 2021- 2031F |
6.2.3 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Bispecific Antibodies Market, 2021- 2031F |
6.2.4 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Fc-engineered Antibodies, 2021- 2031F |
6.2.5 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Next Generation Bio therapeutics Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Brentuximab Vedotin, 2021- 2031F |
6.3.3 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Trastuzumab, 2021- 2031F |
6.3.4 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Next Generation Bio therapeutics Market, By End- Users |
6.4.1 Overview and Analysis |
6.4.2 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 South Korea Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Next Generation Bio therapeutics Market Import-Export Trade Statistics |
7.1 South Korea Next Generation Bio therapeutics Market Export to Major Countries |
7.2 South Korea Next Generation Bio therapeutics Market Imports from Major Countries |
8 South Korea Next Generation Bio therapeutics Market Key Performance Indicators |
8.1 Number of new patents filed for next-generation biotherapeutics in South Korea |
8.2 Percentage of healthcare providers adopting next-generation biotherapeutics in their treatment protocols |
8.3 Investment trends in South Korean biopharmaceutical companies focusing on next-generation biotherapeutics |
8.4 Number of clinical trials conducted for next-generation biotherapeutics in South Korea |
8.5 Research and development expenditure dedicated to biotherapeutics as a percentage of total healthcare expenditure in South Korea |
9 South Korea Next Generation Bio therapeutics Market - Opportunity Assessment |
9.1 South Korea Next Generation Bio therapeutics Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.2 South Korea Next Generation Bio therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 South Korea Next Generation Bio therapeutics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 South Korea Next Generation Bio therapeutics Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 South Korea Next Generation Bio therapeutics Market - Competitive Landscape |
10.1 South Korea Next Generation Bio therapeutics Market Revenue Share, By Companies, 2024 |
10.2 South Korea Next Generation Bio therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here